JD Supra12h
Adapting to the IRA: Early Lessons Learned on the IRA’s Impact on Deal-Making, Drug Economics, and Business Strategy
More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...
dermatologyadvisor15h
Patients With Rheumatoid Arthritis Face Higher COVID-19 Risks
Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...
clinicalpainadvisor.com16h
Higher Adalimumab Trough Levels Improve Outcomes in Rheumatoid Arthritis
Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and ...
Endocrinology Advisor1d
Early Treatment Escalation Fails to Mitigate Risk of Developing D2T RA
Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...
Healio1d
Ivarmacitinib curbs rheumatoid arthritis symptoms, improves function through 52 weeks
A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...
OMNY Health and Scipher Medicine Partner to Revolutionize Autoimmune Disease Treatment with Clinico-Transcriptomics Data
OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which ...